Literature DB >> 20816950

The influence of influenza A (H1N1) virus on creatinine and cystatin C.

Zhidong Guo1, Qiqi Wang, Zhangying Wu, Jianhua Zhu, Yuangang Qiu, Liangrong Zheng, Lifeng Qiu.   

Abstract

BACKGROUND: In March 2009, the novel 2009 influenza A (H1N1) virus was first reported in the southwestern USA and Mexico. It rapidly spread to China and worldwide. We investigated possible kidney injury in patients with the 2009 influenza A (H1N1) virus in China.
METHODS: This study was a retrospective cohort investigation of the potential renal injury in patients of influenza. One hundred and seventy-two patients confirmed to have the 2009 influenza A (H1N1) virus but who had different levels of severity (non-severe, severe, and critically severe) and 21 cases who were influenza A (H1N1)-negative but who had an influenza-like illness were investigated. Blood samples were obtained for the measurement of creatinine (Cr) and cystatin C (Cy-C).
RESULTS: The influenza A (H1N1) virus caused more illness in middle-aged people in all groups. The patients in the non-severe group were younger than those in the severe group (p<0.05) and the non-influenza A (H1N1) group (p<0.01). Four subjects in the critically severe group died (3 due to respiratory failure, 1 heart injury). A significant difference in the levels of Cr and Cy-C between the groups was not observed (p>0.05).
CONCLUSION: The 2009 influenza A (H1N1) virus did not cause severe kidney injury in the acute phase in adult patients. Crown
Copyright © 2010. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816950     DOI: 10.1016/j.cca.2010.08.036

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  1 in total

1.  Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: cohort study.

Authors:  Sean M Bagshaw; Manish M Sood; Jennifer Long; Robert A Fowler; Neill K J Adhikari
Journal:  BMC Nephrol       Date:  2013-06-13       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.